Nuzenio

First Patient Is

First Patient Is news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Innovent Doses First Patient in Phase 3 Trial of IBI363 for Advanced Colorectal Cancer - BioPharma APACBioPharma APAC · Sat, 08 Aug 2026 16:11:09 GMT First Patient Enrolled in Registration-Enabling Amsoki-Cel Melanoma Cohort - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 13:04:40 GMT First patient dosed in clinical study about stroke-related disability - Scientist LiveScientist Live · Fri, 07 Aug 2026 11:17:21 GMT First patient dosed with DISP-10 in Dispatch Bio’s cancer trial - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 10:11:48 GMT Theriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:44:00 GMT SystImmune doses first patient in Phase III trial for ES-SCLC - Clinical Trials ArenaClinical Trials Arena · Thu, 06 Aug 2026 10:25:17 GMT Migraine Biotech Doses First Patient in Phase 2b EVO756 Trial - Streetwise ReportsStreetwise Reports · Thu, 06 Aug 2026 09:41:48 GMT SystImmune Announces First Patient Dosed in Global Phase 3 Trial of BL-M14D1 in First-Line Extensive-Stage Small Cell Lung Cancer - PR NewswirePR Newswire · Wed, 05 Aug 2026 12:00:00 GMT

Timeline

Sat, 08 Aug 2026 16:11:09 GMTInnovent Doses First Patient in Phase 3 Trial of IBI363 for Advanced Colorectal Cancer - BioPharma APAC

Fri, 07 Aug 2026 13:04:40 GMTFirst Patient Enrolled in Registration-Enabling Amsoki-Cel Melanoma Cohort - Targeted Oncology

Fri, 07 Aug 2026 11:17:21 GMTFirst patient dosed in clinical study about stroke-related disability - Scientist Live

Fri, 07 Aug 2026 10:11:48 GMTFirst patient dosed with DISP-10 in Dispatch Bio’s cancer trial - Clinical Trials Arena

Fri, 07 Aug 2026 06:44:00 GMTTheriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial Vanguard

Thu, 06 Aug 2026 10:25:17 GMTSystImmune doses first patient in Phase III trial for ES-SCLC - Clinical Trials Arena

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Trial7 live mentions First7 live mentions Clinical Trials Arena7 live mentions Phase6 live mentions First Patient5 live mentions Registration4 live mentions Patient3 live mentions The Clinical Trial3 live mentions Advanced Colorectal Cancer2 live mentions Doses First Patient2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for First Patient Is.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.